Exploring PTX3 as a Diagnostic and Prognostic Marker in Fetal Inflammatory Response Syndrome in Newborns: A Prospective Study

Öztelcan Gündüz B, Dinleyici EC, Tekin NA, Çolak Ö, Akşit AM.

Open source

DOI
10.20944/preprints202312.0589.v1
Published
2023-12-08
Container
Not recorded
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 39/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.20944/preprints202312.0589.v1,
  title = {Exploring PTX3 as a Diagnostic and Prognostic Marker in Fetal Inflammatory Response Syndrome in Newborns: A Prospective Study},
  author = {Öztelcan Gündüz B and  Dinleyici EC and  Tekin NA and  Çolak Ö and  Akşit AM.},
  year = {2023},
  doi = {10.20944/preprints202312.0589.v1},
  url = {https://doi.org/10.20944/preprints202312.0589.v1}
}

RIS

TY  - JOUR
TI  - Exploring PTX3 as a Diagnostic and Prognostic Marker in Fetal Inflammatory Response Syndrome in Newborns: A Prospective Study
AU  - Öztelcan Gündüz B
AU  -  Dinleyici EC
AU  -  Tekin NA
AU  -  Çolak Ö
AU  -  Akşit AM.
PY  - 2023
DO  - 10.20944/preprints202312.0589.v1
UR  - https://doi.org/10.20944/preprints202312.0589.v1
ER  - 

APA

B, Ö. G., EC, D., NA, T., Ö, Ç., & AM., A. (2023). Exploring PTX3 as a Diagnostic and Prognostic Marker in Fetal Inflammatory Response Syndrome in Newborns: A Prospective Study. https://doi.org/10.20944/preprints202312.0589.v1

Source records